Skip to content

Surgeries

PROCEDURE9 trials

Sponsors

Jiangsu Cancer Institute & Hospital, Henan Cancer Hospital, West China Hospital, Tang-Du Hospital, Chinese PLA General Hospital

Conditions

Esophageal CancerLung CancerNSCLC, Stage INSCLC, Stage IINSCLC, Stage IIINon Small Cell Lung CancerNon-small Cell Lung Cancer

Unknown Phase

An Observational Study to Explore Clinical Characteristics of the Patients With T1 Non-small Cell Lung Cancer
CompletedNCT03413956
Jiangsu Cancer Institute & HospitalNon Small Cell Lung Cancer
Start: 2017-12-01End: 2018-03-30Updated: 2018-05-21
An Observational Study to Evaluate Lymph Metastases and Prognoses of the Patients With Esophageal Cancer
NCT03415815
Henan Cancer HospitalEsophageal Cancer
Start: 2017-12-12End: 2018-04-30Target: 3673Updated: 2018-01-30
A Study to Evaluate Clinical Characteristics of Lung Cancer in Patients With Surgeries and Adjuvant Therapies
CompletedNCT03421093
West China HospitalLung Cancer
Start: 2017-12-01End: 2018-03-30Updated: 2018-05-21
A Observational Study to Compare Effectiveness and Safety of the Surgeries in Patients With Esophageal Cancer
CompletedNCT03428074
Chinese PLA General HospitalEsophageal Cancer
Start: 2017-12-01End: 2018-03-30Updated: 2018-05-21
A Study to Explore Prognoses of NSCLC Patients Complicated With Oligometastases
NCT03427541
Tang-Du HospitalNon Small Cell Lung Cancer
Start: 2017-12-31End: 2018-04-30Target: 1000Updated: 2018-02-09
A Study to Evaluate Effectiveness and Safety of Surgeries in Elderly NSCLC Patients
CompletedNCT03429673
China-Japan Friendship HospitalNon-small Cell Lung Cancer
Start: 2017-12-01End: 2018-03-30Updated: 2018-05-21
A Study to Explore Prognoses of the Patients With N2 Non-small Cell Lung Cancer
CompletedNCT03451526
Tang-Du HospitalNon-small Cell Lung Cancer
Start: 2017-12-01End: 2018-03-30Updated: 2018-05-21
A Real-world Study to Explore Recurrence/Metastases of the NSCLC Patients and the Impact Factors of Patient Survivals
NCT03710616
The First Affiliated Hospital of Guangzhou Medical UniversityNon-small Cell Lung Cancer
Start: 2018-03-24End: 2023-01-01Target: 700Updated: 2019-08-01
A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China
CompletedNCT04830826
The First Affiliated Hospital of Guangzhou Medical UniversityNSCLC, Stage I, NSCLC, Stage II, NSCLC, Stage III
Start: 2020-07-09End: 2025-04-07Updated: 2025-07-30

Related Papers